Last reviewed · How we verify
NCT01504399
Rhinological Outcomes in Endonasal Pituitary Surgery
trial in Pituitary Neoplasm in 235 participants. Completed in 9 December 2015.
1 June 2014
Quick facts
| Lead sponsor | St. Joseph's Hospital and Medical Center, Phoenix |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 235 |
| Start date | 1 October 2011 |
| Primary completion | 1 June 2014 |
| Estimated completion | 9 December 2015 |
| Sites | 4 locations across United States |
Conditions studied
- Pituitary Neoplasm — all drugs for Pituitary Neoplasm →
- Pituitary Adenoma — all drugs for Pituitary Adenoma →
- Prolactinoma — all drugs for Prolactinoma →
- Cushings Disease — all drugs for Cushings Disease →
Sponsor
St. Joseph's Hospital and Medical Center, Phoenix
Who can join
Adults 18 to 80, any sex, with Pituitary Neoplasm or Pituitary Adenoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective, multi-center observational study designed to address patient-reported nasal outcomes in adults undergoing endoscopic and microscopic surgical removal of pituitary tumors. The primary objective of this study is to determine the difference in nasal outcomes by using the Anterior Skull Base (ASK) Nasal survey between patients treated with endoscopic surgical technique and those treated with microscopic surgical technique. Patients will be given the ASK Nasal survey to assess their nasal functioning and overall health before their surgery, and at post-operative visits 1-2 weeks, 3 months, and 6 months.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Predictors of sinonasal quality of life and nasal morbidity after fully endoscopic transsphenoidal surgery.
Little AS, Kelly D, Milligan J, Griffiths C, et al · · 2015 · cited 61× · PMID 25839931 · DOI 10.3171/2014.10.jns141624 -
Comparison of sinonasal quality of life and health status in patients undergoing microscopic and endoscopic transsphenoidal surgery for pituitary lesions: a prospective cohort study.
Little AS, Kelly DF, Milligan J, Griffiths C, et al · · 2015 · cited 49× · PMID 25884256 · DOI 10.3171/2014.10.jns14921 -
Prospective validation of a patient-reported nasal quality-of-life tool for endonasal skull base surgery: The Anterior Skull Base Nasal Inventory-12.
Little AS, Kelly D, Milligan J, Griffiths C, et al · · 2013 · cited 40× · PMID 23662829 · DOI 10.3171/2013.3.jns122032 -
Quality-of-Life after Anterior Skull Base Surgery: A Systematic Review.
Kirkman MA, Borg A, Al-Mousa A, Haliasos N, et al · · 2014 · cited 37× · PMID 24719794 · DOI 10.1055/s-0033-1359303
Verify or expand the search:
- PubMed search for NCT01504399
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pituitary Neoplasm
Currently open trials in the same condition.
- NCT03678389 — Feasibility of Endosphenoidal Coil Placement for Imaging of the Sella During Transsphenoidal Surgery · NA · recruiting
Other St. Joseph's Hospital and Medical Center, Phoenix trials
Trials by the same sponsor.
- NCT06177028 — MCLENA-2: A Phase II Clinical Trial for the Assessment of Lenalidomide in Patients With Mild Cognitive Impairment · Phase 2 · not yet recruiting
- NCT06734286 — Working Memory Training in Patients with Mild Cognitive Impairment · NA · recruiting
- NCT06578195 — ASSESS ALL ALS Study · recruiting
- NCT06581861 — PREVENT ALL ALS Study · recruiting
- NCT06019793 — Electrophysiological Recordings from Deep Brain Stimulation Electrodes for Pain · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01504399 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by St. Joseph's Hospital and Medical Center, Phoenix
- Last refreshed: 22 August 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01504399.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing